Current Pharmaceutical Design
Volume 28, 46 Issues, 2022
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Contents
Current Pharmaceutical Design , Volume 21 - Number 14
Editorial
Editorial
Editorial (Thematic Issue: HSA-Based Drug Development and Drug Delivery Systems)
, 21(14): 1784Feng Yang and Hong Liang
DOI: 10.2174/138161282114150326101436
Understanding the Interaction Between Human Serum Albumin and Anti-Bacterial/ Anti-Cancer Compounds
, 21(14): 1785 - 1799Md Tabish Rehman and Asad U. Khan
DOI: 10.2174/1381612821666150304161201
Studies on Drug – Human Serum Albumin Binding: The Current State of the Matter
, 21(14): 1817 - 1830Zvetanka D. Zhivkova
DOI: 10.2174/1381612821666150302113710
Structure and Enzymatic Activities of Human Serum Albumin
, 21(14): 1831 - 1836Yu Wang, Shihua Wang and Mingdong Huang
DOI: 10.2174/1381612821666150302113906
Drugs Modulate Allosterically Heme-Fe-Recognition by Human Serum Albumin and Heme-Fe-Mediated Reactivity
, 21(14): 1837 - 1847Alessandra di Masi, Loris Leboffe, Viviana Trezza, Gabriella Fanali, Massimo Coletta, Mauro Fasano and Paolo Ascenzi
DOI: 10.2174/1381612821666150302114430
Evaluation of Interactions Between Platinum-/Ruthenium-Based Anticancer Agents and Human Serum Albumin: Development of HSA Carrier for Metal-Based Drugs
, 21(14): 1848 - 1861Yi Gou, Yao Zhang, Feng Yang and Hong Liang
DOI: 10.2174/1381612821666150302114739
Recent Advances on the Development of Pharmacotherapeutic Agents on the Basis of Human Serum Albumin
, 21(14): 1866 - 1888Fang Liu, Jing Mu and Bengang Xing
DOI: 10.2174/1381612821666150302115411
Molecular Imaging and Targeted Drug Delivery Using Albumin-Based Nanoparticles
, 21(14): 1889 - 1898Ji Young Yhee, Jangwook Lee, Hyeyoun Chang, Jeewon Lee, Ick Chan Kwon and Kwangmeyung Kim
DOI: 10.2174/1381612821666150302115809
Recombinant Human Serum Albumin Fusion Proteins and Novel Applications in Drug Delivery and Therapy
, 21(14): 1899 - 1907Brian Rogers, Daoyuan Dong, Zhijun Li and Zhiyu Li
DOI: 10.2174/1381612821666150302120047
The Advancement of Human Serum Albumin-Based Molecular Probes for Molecular Imaging
, 21(14): 1908 - 1915Wei Cao, Xiaoting Lu and Zhen Cheng
DOI: 10.2174/1381612821666150302120517
Editor-in-Chief
Alessandro Antonelli
(12,288 citations)
Department of Clinical and Experimental Medicine
Laboratory of Primary Human Cells
University of Pisa
Pisa
(Italy)
Biography
(12,288 citations)
Department of Clinical and Experimental Medicine
Laboratory of Primary Human Cells
University of Pisa
Pisa
Biography
Biography of Alessandro Antonelli
Alessandro Antonelli (Professor of Internal Medicine, MD) is Director of the Immuno-Endocrine
Section of Internal Medicine, and Head of the Laboratory of Primary Human Cells, University of
Pisa. His principal areas of expertise are autoimmune thyroid disorders, type 1 diabetes, systemic
autoimmune disorders, chemokines and cytokines, HCV-associated thyroid disorders and thyroid
cancer. His researches have been published in more than 370 articles on International journals
(Impact Factor > 1600; HI=75). He serves as an editorial board member and is Referee and
Reviewer of many scientific International journals.
Nobel Laureate on Editorial Board
Andrew V. Schally
(USA)
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Pharmaceutical Design was introduced in 1995. Prof. Alessandro Antonelli serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net